Humulin RU 500

Indications

Humulin R U-500 is a concentrated form of insulin used to improve blood sugar control in adults and children with diabetes mellitus. It is used for both type 1 and type 2 diabetes.

Concentrated Insulin Use

This medication is specifically intended for people with diabetes who require high daily doses of insulin to manage their blood sugar. Because it is five times more concentrated than standard insulin, it allows for the delivery of a large dose in a smaller injection volume. It is generally prescribed when a patient has developed significant insulin resistance and standard insulin concentrations are no longer practical for their needs.

Humulin R U-500 is used as an addition to diet and exercise. Proper management of blood sugar helps reduce the risk of long-term health problems related to diabetes.

Mechanism of Action

Humulin R U-500 is a man-made version of the hormone insulin. It works by mimicking the natural insulin produced by the pancreas to regulate blood sugar levels. When blood sugar is high, insulin acts as a key that allows glucose to enter the body's cells to be used for energy.

This medication lowers blood sugar through several processes:

• Promoting Glucose Absorption: It encourages muscle and fat cells to take in glucose from the blood.
• Reducing Sugar Production: It signals the liver to stop making and releasing more sugar into the bloodstream.
• Managing Metabolism: It helps the body store nutrients and prevents the breakdown of fats and proteins for energy.

Concentration and Duration

Humulin R U-500 is five times more concentrated than standard U-100 insulin. Because of this high concentration, the body absorbs it differently than standard regular insulin. It begins working quickly to manage blood sugar after meals, but it also stays in the system longer. This allows it to provide a steady level of insulin coverage throughout the day, similar to intermediate-acting insulins.

Common Side Effects

The most frequent side effect of insulin therapy is low blood sugar (hypoglycemia). Other common side effects include:

• Weight gain
• Swelling in the hands or feet
• Skin changes at the injection site, such as thickening, pits, or lumps (lipodystrophy)
• Itching or mild rash
• Redness, pain, or swelling where the injection was given

Serious Side Effects

Some side effects can be severe and require immediate medical attention:

• Severe hypoglycemia: This can lead to dizziness, confusion, blurred vision, slurred speech, shakiness, fast heartbeat, seizure, or loss of consciousness.
• Severe allergic reactions: Symptoms may include a rash over the whole body, trouble breathing, wheezing, fast pulse, or feeling like you might pass out.
• Low potassium (hypokalemia): This may cause muscle cramps, weakness, or abnormal heart rhythms.
• Heart failure: Taking certain diabetes medications called thiazolidinediones (TZDs) with insulin may increase the risk of heart failure. Symptoms include shortness of breath, swelling of the ankles or feet, and sudden weight gain.

Dosing Errors and Concentration

Humulin R U-500 is five times more concentrated than standard U-100 insulin. Because of this high concentration, even small errors in measurement can result in a dangerous overdose or underdose. To prevent these errors, this insulin must only be administered using a dedicated U-500 insulin syringe. Using other types of syringes, such as U-100 or tuberculin syringes, can lead to incorrect dosing and severe health consequences.

Hypoglycemia (Low Blood Sugar)

Hypoglycemia is the most common side effect of all insulin products, including Humulin R U-500. Severe low blood sugar can cause seizures, unconsciousness, or death. The timing of hypoglycemia depends on the insulin action profile and can change with factors such as meal patterns, physical activity, or changes to other medications. Frequent blood glucose monitoring is recommended for all patients using insulin.

Hypersensitivity and Allergic Reactions

Severe, life-threatening allergic reactions, including anaphylaxis, can occur. Symptoms may include a whole-body rash, shortness of breath, wheezing, fast pulse, or sweating. If a serious allergic reaction occurs, the medication should be stopped immediately and medical help sought.

Hypokalemia (Low Potassium)

All insulin products can cause a shift in potassium levels from the blood into the cells, potentially leading to hypokalemia. If left untreated, low potassium can cause respiratory paralysis, heart rhythm problems, and death. Monitoring is especially important for patients at risk, such as those using potassium-lowering medications.

Fluid Retention and Heart Failure

When used in combination with certain diabetes medications called thiazolidinediones (TZDs), insulin can cause fluid retention and heart failure. Patients should be monitored for signs of heart failure, such as shortness of breath, swelling of the ankles or feet, and sudden weight gain.

Administration and Mixing

Humulin R U-500 should only be injected into the tissue under the skin (subcutaneously). It must not be administered intravenously or intramuscularly. This insulin should never be mixed with any other insulin products or liquids, as mixing can change how the insulin works in the body.

Contraindications

Humulin R U-500 should not be used during episodes of hypoglycemia. It is also contraindicated for patients who have a known hypersensitivity to Humulin R U-500 or any of its ingredients.

Pregnancy

Maintaining stable blood sugar levels is essential for the health of both the mother and the developing fetus. Poorly controlled diabetes during pregnancy can increase the risk of complications, such as preeclampsia, birth defects, and pregnancy loss. Studies on human insulin have not shown a clear link between its use and an increased risk of major birth defects or miscarriage.

Insulin requirements often fluctuate during pregnancy:

• First trimester: Insulin needs may decrease.
• Second and third trimesters: Insulin needs typically increase.

Close monitoring of blood glucose levels is usually recommended for individuals using insulin while pregnant to ensure dosages are adjusted as needed.

Breastfeeding

Human insulin is a natural component of breast milk. Research indicates that using insulin while breastfeeding does not cause adverse effects in the nursing infant or interfere with milk production. However, insulin requirements may change during the postpartum period and while breastfeeding, so ongoing monitoring and consultation with a healthcare provider are important.

Available Forms

This concentrated insulin human injection is available in two primary delivery systems:

• Multiple-dose Vial: This form is used with a dedicated syringe specifically designed for this concentration.
• KwikPen: This is a prefilled, disposable delivery device used to dial and inject the medication.

These forms are for subcutaneous injection only and should not be used in insulin pumps or administered intravenously.

FDA Approval and Indications

Humulin R U-500 (insulin human injection) is FDA-approved to improve glycemic control in adults and children with type 1 or type 2 diabetes mellitus. It is specifically indicated for patients who require more than 200 units of insulin per day due to severe insulin resistance.

Safety Communications and Dosing Precautions

Because Humulin R U-500 is five times more concentrated than standard U-100 insulin, the FDA has issued specific safety communications to prevent dosing errors. These errors can lead to severe hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar).

• Dedicated Syringes: The FDA approved a dedicated U-500 insulin syringe specifically for use with the U-500 vial. This syringe is designed to measure the dose in actual units of insulin, which helps avoid the need for manual dose conversions.
• KwikPen Delivery: The medication is also available in a pre-filled KwikPen. This device is calibrated to dial the correct dose in units, further reducing the risk of calculation errors.
• Warning Against Syringe Mixing: Regulatory labeling warns that patients should never use a standard U-100 syringe or a tuberculin syringe with the U-500 vial. Using the wrong syringe type is a major cause of dangerous medication errors.

Regulatory Status

There are currently no Boxed Warnings or Risk Evaluation and Mitigation Strategies (REMS) required for Humulin R U-500. However, the FDA-approved labeling includes strict instructions for healthcare providers to ensure patients are trained on the correct delivery device to prevent administration mistakes.

Concentrated Insulin Therapy

Humulin R U-500 contains 500 units of insulin per milliliter (mL), making it five times more concentrated than standard U-100 insulin. Because of this high concentration, it is typically reserved for patients with severe insulin resistance who need more than 200 units of insulin each day.

How It Works

While classified as a regular human insulin, the high concentration of U-500 changes how the body absorbs it. It provides a rapid onset of action to cover meals, but it also has a prolonged duration of effect that can last up to 24 hours. This allows it to function as both a mealtime and a background insulin.

Administration and Safety

Due to its potency, precise dosing is critical to prevent life-threatening hypoglycemia (low blood sugar). It must only be administered using the following methods:

• U-500 KwikPen: A prefilled pen that dials the dose in actual units.
• U-500 Specific Syringe: If using a vial, only a syringe specifically designed for U-500 insulin should be used. Standard U-100 syringes should never be used as they will result in a dangerous dosing error.

This insulin is for subcutaneous (under the skin) injection only. It should never be administered intravenously or through an insulin pump unless specifically directed by a healthcare provider using compatible equipment.